MAPT and Creutzfeldt Jacob disease: Importantly, NT1-tau levels were associated with functional decline and rate of clinical progression, and a known modifier of CJD phenotype, polymorphism of the prion gene (PRNP) at codon 129, influenced the rate of clinical progression [29,30,31,32].